Arrayit Corporation announced today that a 16-page positive research report on the company has been published by one of the nation’s leading micro-cap research firms, Grass-Roots-Research. The report can be viewed on the research firm’s website at

The report stated, “We believe that the Company’s plan to enter into the molecular diagnostics segment presents a substantial growth opportunity. Arrayit is a potentially lucrative opportunity for risk adverse investors.”

Grass-Roots-Research established a base case target price of $6.49, which is considerably higher than today’s market price of $1.45 per share.